Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -62.14% is 22% above its 5-year average of -79.44%, near the high end of its 5-year range (-150.89%–-50.59%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.74% above its 12-month average of -69.62%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -62.14%.
RETURN ON INVESTED CAPITAL (ROIC)
-62.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-69.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-83.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-79.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+10.74%
CURRENT VS 3Y AVG
+25.89%
CURRENT VS 5Y AVG
+21.77%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-24.33%
median of 365 covered companies
CURRENT VS SECTOR MEDIAN
-155.40%
vs the sector median at left
BridgeBio Pharma, Inc.
Market Cap
$12.95B
Return on Invested Capital (ROIC)
-62.14%
TTM Avg
-69.62%
3Y Avg
-83.85%
5Y Avg
-79.44%
Market Cap
$12.89B
Return on Invested Capital (ROIC)
4.80%
TTM Avg
6.92%
3Y Avg
6.32%
5Y Avg
7.02%
Market Cap
$13.19B
Return on Invested Capital (ROIC)
0.87%
TTM Avg
11.88%
3Y Avg
15.16%
5Y Avg
18.34%
Market Cap
$12.52B
Return on Invested Capital (ROIC)
-1.61%
TTM Avg
-0.86%
3Y Avg
-2.74%
5Y Avg
0.22%
Market Cap
$12.49B
Return on Invested Capital (ROIC)
8.48%
TTM Avg
7.10%
3Y Avg
4.92%
5Y Avg
2.27%
Market Cap
$12.17B
Return on Invested Capital (ROIC)
8.97%
TTM Avg
4.70%
3Y Avg
4.24%
5Y Avg
4.03%
Market Cap
$12.00B
Return on Invested Capital (ROIC)
13.42%
TTM Avg
12.59%
3Y Avg
14.85%
5Y Avg
11.33%
Market Cap
$14.16B
Return on Invested Capital (ROIC)
5.85%
TTM Avg
-27.36%
3Y Avg
-53.87%
5Y Avg
-49.45%
Market Cap
$11.47B
Return on Invested Capital (ROIC)
11.18%
TTM Avg
11.30%
3Y Avg
9.75%
5Y Avg
9.57%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | $12.95B | -62.14% | -69.62% | -83.85% | -79.44% |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 4.80% | 6.92% | 6.32% | 7.02% |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 0.87% | 11.88% | 15.16% | 18.34% |
| Baxter International Inc. (BAX)vs › | $12.52B | -1.61% | -0.86% | -2.74% | 0.22% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 8.48% | 7.10% | 4.92% | 2.27% |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 8.97% | 4.70% | 4.24% | 4.03% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 13.42% | 12.59% | 14.85% | 11.33% |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | 5.85% | -27.36% | -53.87% | -49.45% |
| DaVita Inc. (DVA)vs › | $11.47B | 11.18% | 11.30% | 9.75% | 9.57% |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 7.86% | 5.36% | 7.03% | 8.47% |
ROIC
-62.1%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -62.14% |
| 2026-03-31 | -50.59% |
| 2025-12-31 | -85.52% |
| 2025-09-30 | -78.02% |
| 2025-06-30 | -71.82% |
| 2025-03-31 | -95.63% |
| 2024-12-31 | -77.52% |
| 2024-09-30 | -103.54% |
| 2024-06-30 | -76.78% |
| 2024-03-31 | -67.93% |
| 2023-12-31 | -150.89% |
| 2023-09-30 | -101.87% |
| 2023-06-30 | -134.83% |
| 2023-03-31 | -87.22% |
| 2022-12-31 | -102.11% |
| 2022-09-30 | -90.00% |
| 2022-06-30 | -78.91% |
| 2022-03-31 | -82.12% |
| 2021-12-31 | -65.70% |
| 2021-09-30 | -78.53% |
| 2021-06-30 | -53.33% |
| 2021-03-31 | -53.63% |
| 2020-12-31 | -77.86% |
| 2020-09-30 | -59.48% |
| 2020-06-30 | -44.13% |
| 2020-03-31 | -32.97% |
| 2019-12-31 | -46.60% |
| 2019-09-30 | -42.15% |
| 2019-06-30 | -83.71% |
| 2019-03-31 | -56.18% |
| 2018-12-31 | -42.48% |
